Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Discovery of sulfonamide-tethered isatin derivatives as novel anticancer agents and VEGFR-2 inhibitors
Moataz A. Shaldam, Hadia Almahli, Andrea Angeli, et al.
Journal of Enzyme Inhibition and Medicinal Chemistry (2023) Vol. 38, Iss. 1
Open Access | Times Cited: 33

Showing 1-25 of 33 citing articles:

Discovery of Novel Pyridazine-Tethered Sulfonamides as Carbonic Anhydrase II Inhibitors for the Management of Glaucoma
Haytham O. Tawfik, Mohamed M. Saleh, Andrea Ammara, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 2, pp. 1611-1623
Closed Access | Times Cited: 16
Discovery and Mechanistic Studies of Dual-Target Hits for Carbonic Anhydrase IX and VEGFR-2 as Potential Agents for Solid Tumors: X-ray, In Vitro, In Vivo, and In Silico Investigations of Coumarin-Based Thiazoles
Salma M. Hefny, Tarek F. El‐Moselhy, Nabaweya Sharaf El-Din, et al.
Journal of Medicinal Chemistry (2024) Vol. 67, Iss. 9, pp. 7406-7430
Closed Access | Times Cited: 15
A new framework for novel analogues of pazopanib as potent and selective human carbonic anhydrase inhibitors: Design, repurposing rational, synthesis, crystallographic, in vivo and in vitro biological assessments
Salma M. Hefny, Tarek F. El‐Moselhy, Nabaweya Sharaf El-Din, et al.
European Journal of Medicinal Chemistry (2024) Vol. 274, pp. 116527-116527
Closed Access | Times Cited: 15
Efficient synthesis and molecular docking analysis of quinazoline and azole hybrid derivatives as promising agents for anti-cancer and anti-tuberculosis activities
Gourav Kumar, Parveen Kumar, Akta Soni, et al.
Journal of Molecular Structure (2024) Vol. 1310, pp. 138289-138289
Closed Access | Times Cited: 10
Novel sulfonamide-tethered Schiff bases as anti-proliferative agents with VEGFR-2 inhibitory activity: Synthesis, biological assessment, and molecular dynamic simulations
Moataz A. Shaldam, Maha-Hamadien Abdulla, Andrea Angeli, et al.
Journal of Molecular Structure (2024) Vol. 1309, pp. 138148-138148
Closed Access | Times Cited: 8
Unveiling the potential of isatin-grafted phenyl-1,2,3-triazole derivatives as dual VEGFR-2/STAT-3 inhibitors: Design, synthesis and biological assessments
Heba A. Elsebaie, Maha-Hamadien Abdulla, Zainab M. Elsayed, et al.
Bioorganic Chemistry (2024) Vol. 151, pp. 107626-107626
Closed Access | Times Cited: 8
In Vitro Enzymatic and Computational Assessments of Pyrazole–Isatin and Pyrazole–Indole Conjugates as Anti-Diabetic, Anti-Arthritic, and Anti-Inflammatory Agents
Ahmed M. Naglah, Abdulrahman A. Almehizia, Mohammed Ghazwani, et al.
Pharmaceutics (2025) Vol. 17, Iss. 3, pp. 293-293
Open Access | Times Cited: 1
Targeting carbonic anhydrases for the management of hypoxic metastatic tumors
Claudiu T. Supuran
Expert Opinion on Therapeutic Patents (2023) Vol. 33, Iss. 11, pp. 701-720
Closed Access | Times Cited: 22
Discovery of new sulfonamide-tethered 2-aryl-4-anilinoquinazolines as the first-in-class dual carbonic anhydrase and EGFR inhibitors
Wagdy M. Eldehna, Zainab M. Elsayed, Andrea Ammara, et al.
International Journal of Biological Macromolecules (2024) Vol. 279, pp. 135010-135010
Closed Access | Times Cited: 7
Recent drug design strategies and identification of key heterocyclic scaffolds for promising anticancer targets
Alia Mushtaq, Peng Wu, Muhammad Moazzam Naseer
Pharmacology & Therapeutics (2023) Vol. 254, pp. 108579-108579
Closed Access | Times Cited: 13
Synthesis and biological Evaluation of novel Isatin-Phenol hybrids as potential antitumor agents
Zhuo Chen, Yishan Guo, Yuwei Peng, et al.
Bioorganic Chemistry (2025), pp. 108232-108232
Closed Access
Exploring the potential of isatin hybrids as anticancer agents: recent advances and future prospective
Parveen Gahlyan, Tushar Chauhan, Priyanka Jhajharia, et al.
Medicinal Chemistry Research (2025)
Closed Access
Design, Synthesis, and Cytotoxicity Evaluation of Novel Indolin-2-One Based Molecules on Hepatocellular Carcinoma HepG2 Cells as Protein Kinase Inhibitors
Manal M. Kandeel, Mohammed K. Abdelhameid, Mohamed A. Said, et al.
Molecules (2025) Vol. 30, Iss. 5, pp. 1105-1105
Open Access
Sulfonamides a Promising Hit for Cancer Therapy Through VEGFR-2 Inhibition
Eleftherios Charissopoulos, Eleni Pontiki
Biomedicines (2025) Vol. 13, Iss. 4, pp. 772-772
Open Access
Design and synthesis of 1-methyl-2-oxoindolin-3-ylidene-thiazolidine-2,4-dione-pyrazole hybrids as VEGFR-2 targeting anti-proliferative agents
Madhu Rao, Kotni Hari Gangadhar, Rajesh Madhu, et al.
Journal of Molecular Structure (2025), pp. 142162-142162
Closed Access
A scaffold repositioning approach: dihydroBenzoImidazoTriazineDione (BITD) derivatives as selective ALDH1A1 inhibitors
Bianca Laura Bernardoni, Ilaria D’Agostino, Sonia Siragusa, et al.
Molecular Diversity (2025)
Closed Access
Novel benzofuran-conjugated indolin-2-ones as anticancer agents; design, synthesis, biological assessments, and molecular modeling insights
Wagdy M. Eldehna, Haytham O. Tawfik, Mohamed S. Nafie, et al.
Bioorganic Chemistry (2025), pp. 108494-108494
Closed Access
Development of novel cyclopropyl tethered iminothiazolidinone-isatin hybrids as effective multi target intestinal alkaline phosphatase, urease and α-glucosidase inhibitors
Haider Zaman, Aamer Saeed, Tamknat ul Muntaha, et al.
International Journal of Biological Macromolecules (2025) Vol. 310, pp. 143377-143377
Closed Access
Exploring antitumor activity of novel imidazo[2,1-b]thiazole and imidazo[1,2-a]pyridine derivatives on MDA-231 cell line: targeting VEGFR-2 enzyme with computational insight
Mohamed K. Elgohary, Mahmoud S. Elkotamy, Sara T. Al‐Rashood, et al.
Journal of Molecular Structure (2024) Vol. 1322, pp. 140579-140579
Closed Access | Times Cited: 3
Design, Synthesis, Molecular Docking, and Biological Evaluation of Isatin-Based Fused Heterocycles As Epidermal Growth Factor Receptor Inhibitors
Ankush Kumar, Bhupinder Kumar, Rohit Bhatia
Assay and Drug Development Technologies (2023) Vol. 21, Iss. 5, pp. 222-233
Closed Access | Times Cited: 8
Synthesis, cytotoxic evaluation, apoptosis, cell cycle, and molecular docking studies of some new 5-(arylidene/heteroarylidene)-2-(morpholinoimino)-3-phenylthiazolidin-4-ones
Mohammed A. Assiri, Tarik E. Ali, Maha N. Alqahtani, et al.
Synthetic Communications (2023) Vol. 53, Iss. 15, pp. 1240-1261
Closed Access | Times Cited: 7
Computational insights into novel benzenesulfonamide-1,3,4-thiadiazole hybrids as a possible VEGFR-2 inhibitor: design, synthesis and anticancer evaluation with molecular dynamics studies
Samir Bondock, Tallah Albarqi, Moaz M. Abdou, et al.
New Journal of Chemistry (2023) Vol. 47, Iss. 44, pp. 20602-20618
Closed Access | Times Cited: 7
Computational, Reactivity, Fukui Function, Molecular Docking, and Spectroscopic Studies of a Novel (E)-1-Benzyl-3-(2-(Pyrindin-2-yl)Hydrazono)Indolin-2-One
Dhakshinamurthy Divya, Venkatesan Srinivasan, A. Prabakaran, et al.
Polycyclic aromatic compounds (2023), pp. 1-21
Closed Access | Times Cited: 7
Natural Isatin Derivatives Against Black Fungus: In Silico Studies
Md. Saddam Hossain, Md. Anisur Rahman, Prithbey Raj Dey, et al.
Current Microbiology (2024) Vol. 81, Iss. 5
Closed Access | Times Cited: 2
Synthesis, Invitro Cytotoxic Activity and Optical Analysis of Substituted Schiff Base Derivatives
M. Saleem, Abrar Hussain, Muhammad Hanif, et al.
Journal of Fluorescence (2024)
Closed Access | Times Cited: 2
Page 1 - Next Page

Scroll to top